As TRIP13 has a role in promoting CRC progression, we tested the hypothesis that pharmacologic inhibition of TRIP13 by DCZ0415 inhibits primary and metastatic tumour growth. This evidence concerns the gene TRIP13 and colorectal carcinoma.